721 research outputs found
Serum Levels of Selenium, Zinc, Copper and Magnesium in Asthmatic Patients: a Case Control Study.
Background: Free radicals have harmful effects on cells and tissues and are thought to be responsible for the pathogenesis of many diseases including bronchial asthma. Selenium (Se), Zinc (Zn), copper (Cu), and magnesium (Mg) are trace elements
required for the antioxidant enzymes and hence the optimal functions of the immune system. Changes in the levels of these elements may lead to a reduction in antioxidant activities in asthma.
Objective: This study was conducted to determine serum levels of the trace elements Se, Zn, Cu, and Mg in asthmatic patients in order to evaluate the associations of these nutrients
with asthma in adults
Subjects and Methods: Serum Se, Zn, Cu, and Mg concentrations were measured in 100 asthmatic adult patients and 170 healthy control subjects matched for age and sex. The patients were recruited from asthma casualties, referred clinics and wards of Elshaab and Omdurman Teaching Hospital, Khartoum Sudan. Socio- demographic data and clinical history of all subjects were collected in questionnaires.
Results: Serum Se and Cu levels were found to be significantly decreased in asthmatic patients compared to controls. Mean serum Se and Cu for patients were 65.8 5.5Ig/l (mean SD) and 0.711 0.37g/l respectively while that for controls were 78.2 7.5 Ig/l and 0.939 0.322g/l respectively (P value was < 0.001). On the other hand the mean serum Zn level was significantly higher in patients compared to controls (1.2 0.51g/l and 0.94 0.254g/l respectively) (P value wa
Prospective evaluation of the impact of post-cesarean section uterine scarification in the perinatal diagnosis of placenta accreta spectrum
Objective:
Standardized ultrasound imaging and pathology protocols have recently been developed for the perinatal diagnosis of placenta accreta spectrum (PAS) disorders. The aim of this study was to evaluate prospectively the effectiveness of these standardized protocols in the prenatal diagnosis and postnatal examination of women presenting with a low-lying placenta or placenta previa and a history of multiple Cesarean deliveries (CDs).
Methods:
This was a prospective cohort study of 84 consecutive women with a history of two or more prior CDs presenting with a singleton pregnancy and low-lying placenta/placenta previa at 32–37 weeks' gestation, who were referred for perinatal care and management between 15 January 2019 and 15 December 2020. All women were investigated using the standardized description of ultrasound signs of PAS proposed by the European Working Group on abnormally invasive placenta. In all cases, the ultrasound features were compared with intraoperative and histopathological findings. Areas of abnormal placental attachment were identified during the immediate postoperative gross examination and sampled for histological examination. The data of a subgroup of 32 women diagnosed antenatally as non-PAS who had complete placental separation at birth were compared with those of 39 cases diagnosed antenatally as having PAS disorder that was confirmed by histopathology at delivery.
Results:
Of the 84 women included in the study, 42 (50.0%) were diagnosed prenatally as PAS and the remaining 42 (50.0%) as non-PAS on ultrasound examination. Intraoperatively, 66 (78.6%) women presented with a large or extended area of dehiscence and 52 (61.9%) with a dense tangled bed of vessels or multiple vessels running laterally and craniocaudally in the uterine serosa. A loss of clear zone was recorded on grayscale ultrasound imaging in all 84 cases, while there was no case with bladder-wall interruption or with a focal exophytic mass. Myometrial thinning (< 1 mm) in at least one area of the anterior uterine wall was found in 41 (97.6%) of the 42 cases diagnosed as non-PAS on ultrasound and 37 (88.1%) of the 42 diagnosed antenatally as PAS. Histological samples were available for all 48 hysterectomy specimens with abnormal placental attachment and for the three cases managed conservatively with focal myometrial resection and uterine reconstruction. Villous tissue was found directly attached to the superficial myometrium (placenta creta) in six of these cases and both creta villous tissue and deeply implanted villous tissue within the uterine wall (placenta increta) were found in the remaining 45 cases. There was no evidence of percreta placentation on histology in any of the PAS cases. Comparison of the main antenatal ultrasound signs and perioperative macroscopic findings between the two subgroups correctly diagnosed antenatally (32 non-PAS and 39 PAS) showed no significant difference with respect to the distribution of myometrial thinning and the presence of a placental bulge on ultrasound and of anterior uterine wall dehiscence intraoperatively. Compared with the non-PAS subgroup, the PAS subgroup showed significantly higher placental lacunae grade (P < 0.001) and more often hypervascularity of the uterovesical/subplacental area (P < 0.001), presence of bridging vessels (P = 0.027) and presence of lacunae feeder vessels (P < 0.001) on ultrasound examination, and increased vascularization of the anterior uterine wall intraoperatively (P < 0.001).
Conclusions:
Remodeling of the lower uterine segment following CD scarring leads to structural abnormalities of the uterine contour on both ultrasound examination and intraoperatively, independently of the presence of accreta villous tissue on microscopic examination. These anatomical changes are often reported as diagnostic of placenta percreta, including cases with no histological evidence of PAS. Guided histological examination could improve the overall diagnosis of PAS and is essential to obtain evidence-based epidemiologic data. © 2021 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology
Assessment of ultrasound features of placenta accreta spectrum in women at high risk: association with outcome and interobserver concordance
OBJECTIVES: The aims of this study were to evaluate the prenatal ultrasound features associated with operative complications and to assess the interobserver agreement in a cohort with detailed intraoperative and histopathologic data. METHODS: We conducted a retrospective, multicentre cohort study of 102 patients at high-risk of placenta accreta spectrum (PAS) between January 2019 and May 2022. De-identified ultrasound images were reviewed retrospectively and independently by two experienced operators blinded to clinical details, intra-operative features, outcome, and the histopathologic findings. The diagnosis of PAS was confirmed by the failure of detachment of one or more placental cotyledon from the uterine wall at delivery and the absence of decidua with distortion of the utero-placental interface by fibrinoid deposition on histologic examination of the accreta areas obtained by guided-sampling of partial myometrial resection or hysterectomy specimens. Antenatal categorisation was low or high probability of the likelihood of PAS at birth. Interobserver agreement was assessed using kappa statistic. Primary outcome was major operative morbidity (blood loss of ≥2000 ml, unintentional injury to the viscera, admission to intensive care unit or death). RESULTS: There were 66 cases with, and 36 cases without evidence PAS at birth. When blinded to other clinical details, the examiners agreed on the low or high probability of PAS in 87/102 cases (73.5%) on ultrasound features. The kappa statistic is 0.47 (95% CI: 0.28 - 0.66) showing moderate agreement. Morbidity was twice as common with a diagnosis of PAS. Concordant assessment of high probability of PAS was associated with the highest morbidity (66.6%) and a high (97.6%) chance of histopathological confirmation. CONCLUSIONS: The probability of histopathological confirmation is exceedingly high with concordant prenatal assessment suggestive of PAS. The interoperator agreement for preoperative assessment for histopathological confirmation of PAS is only moderate. Morbidity is linked to both histopathological diagnosis and antenatal assessment concordant of PAS. This article is protected by copyright. All rights reserved
Nimrud and its Remains In Light of Iraqi Excavations From 1989-2002
This article presents the Iraqi excavations undertaken by the Department of Antiquities and Heritage, and later the State Board of Antiquities and Hertiage, that started in the 1980s and continued until shortly before the outbreak of the 2003 war. What started as primarily restoration work at the Northwest Palace in Nimrud and some of the major temples on the citadel, soon transformed to excavations throughout various parts of the Nimrud citadel, as major discoveries, including the Queens' tombs, were made. We present here the results of excavations on the Nimrud citadel that have not previously been published or only published in short detail in other volumes
Balancing carrots and sticks: incentives for sustainable hilsa fishery management in Bangladesh
Mihir Kanti Majumder, Md Mokammel Hossain, Atiq Rahman, Belayet Hussei
Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients
Background: Hepatocellular carcinoma (HCC) is the fifth most common
malignancy in the world. In Egypt, HCC was reported to account for
about 4.7% of chronic liver disease (CLD) patients. Squamous cell
carcinoma antigen (SCCA) has been reported to be strongly expressed in
HCC tissue hampering its extensive use in clinical practice. Aim: To
evaluate the clinical usefulness of serum SCCA levels as a serological
marker for early detection of HCC among high-risk patients compared to
AFP. Materials and Methods: The study comprised of three groups.
Group A included 30 patients with CLD diagnosed based on clinical,
laboratory, and ultrasonographical investigations; group B included 49
patients with HCC diagnostically confirmed by spiral CT, elevated
alfafetoprotein (AFP), and/or liver biopsy; and group C, the control
group, included 15 healthy subjects matched for age and sex. All groups
were subjected to thorough history taking, full clinical examination,
and laboratory investigations including liver functions, viral markers,
and AFP and SCCA estimation using ELISA technique. Results: This study
revealed a highly significant difference between patients with HCC,
CLD, and controls regarding serum SCCA levels (5.138 ± 7.689,
1.133 ± 0.516, and 0.787 ± 0.432 ng/ml, respectively). SCCA
level was persistently elevated in patients with HCC with normal AFP
levels representing its useful role in early detection and follow-up of
patients treated for HCC. The area under the curve (AUC) of SCCA was
0.869 (95% CI 0.783-0.929), the cut-off value was established at 1.5
ng/ml with sensitivity of 77.6% and specificity of 84.4%). The
difference between AUC of SCCA and that of AFP was 0.09 which mounted
statistical significance. Conclusions: SCCA could represent a useful
tool as a marker for detection of HCC
Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients
Background: Hepatocellular carcinoma (HCC) is the fifth most common
malignancy in the world. In Egypt, HCC was reported to account for
about 4.7% of chronic liver disease (CLD) patients. Squamous cell
carcinoma antigen (SCCA) has been reported to be strongly expressed in
HCC tissue hampering its extensive use in clinical practice. Aim: To
evaluate the clinical usefulness of serum SCCA levels as a serological
marker for early detection of HCC among high-risk patients compared to
AFP. Materials and Methods: The study comprised of three groups.
Group A included 30 patients with CLD diagnosed based on clinical,
laboratory, and ultrasonographical investigations; group B included 49
patients with HCC diagnostically confirmed by spiral CT, elevated
alfafetoprotein (AFP), and/or liver biopsy; and group C, the control
group, included 15 healthy subjects matched for age and sex. All groups
were subjected to thorough history taking, full clinical examination,
and laboratory investigations including liver functions, viral markers,
and AFP and SCCA estimation using ELISA technique. Results: This study
revealed a highly significant difference between patients with HCC,
CLD, and controls regarding serum SCCA levels (5.138 \ub1 7.689,
1.133 \ub1 0.516, and 0.787 \ub1 0.432 ng/ml, respectively). SCCA
level was persistently elevated in patients with HCC with normal AFP
levels representing its useful role in early detection and follow-up of
patients treated for HCC. The area under the curve (AUC) of SCCA was
0.869 (95% CI 0.783-0.929), the cut-off value was established at 1.5
ng/ml with sensitivity of 77.6% and specificity of 84.4%). The
difference between AUC of SCCA and that of AFP was 0.09 which mounted
statistical significance. Conclusions: SCCA could represent a useful
tool as a marker for detection of HCC
Recommended from our members
Assessment of ultrasound features of placenta accreta spectrum in women at high risk: association with outcome and interobserver concordance.
OBJECTIVES: To evaluate the prenatal ultrasound features associated with operative complications and to assess the interobserver agreement of prenatal ultrasound assessment with histopathologic confirmation of placenta accreta spectrum (PAS) in a cohort of high-risk patients with detailed intraoperative and histopathologic data. METHODS: This was a retrospective multicenter cohort study of patients at high risk of PAS referred for specialist perinatal care and management between January 2019 and May 2022. Deidentified ultrasound images were reviewed independently by two experienced operators blinded to clinical details, intraoperative features, outcome and histopathologic findings. The diagnosis of PAS was confirmed by failure of detachment of one or more placental cotyledons from the uterine wall at delivery, and the absence of decidua with distortion of the uteroplacental interface by fibrinoid deposition on histologic examination of the accretic areas obtained by guided sampling of partial myometrial resection or hysterectomy specimens. Patients were categorized as having a low or high likelihood of PAS at birth. Interobserver agreement of prenatal ultrasound assessment with histopathologic confirmation of PAS was assessed using the kappa statistic. Primary outcome was major operative morbidity (blood loss ≥ 2000 mL, unintentional injury to the viscera, admission to intensive care unit or death). RESULTS: A total of 102 women at high risk of PAS were referred, of whom 66 had evidence of PAS at birth and 36 did not. When blinded to other clinical details, the examiners agreed on the low or high probability of PAS, according to ultrasound features, in 75/102 cases (73.5%). The kappa statistic was 0.47 (95% CI, 0.28-0.66), showing moderate agreement. Morbidity was twice as common with concordant prenatal diagnosis of PAS vs concordant diagnosis of not PAS. Concordant assessment of high probability of PAS was associated with the highest morbidity (66.6%) and a very high (97.6%) likelihood of histopathologic confirmation. CONCLUSIONS: The probability of histopathologic confirmation is very high with concordant prenatal assessment suggestive of PAS. The interobserver agreement for preoperative assessment with histopathologic confirmation of PAS is only moderate. Morbidity is associated with both histopathologic diagnosis and concordant antenatal assessment of PAS. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology
Self-Reported Occupational Exposure to HIV and Factors Influencing its Management Practice: A Study of Healthcare Workers in Tumbi and Dodoma Hospitals, Tanzania.
Blood borne infectious agents such as hepatitis B virus (HBV), hepatitis C virus (HCV) and human immune deficiency virus (HIV) constitute a major occupational hazard for healthcare workers (HCWs). To some degree it is inevitable that HCWs sustain injuries from sharp objects such as needles, scalpels and splintered bone during execution of their duties. However, in Tanzania, there is little or no information on factors that influence the practice of managing occupational exposure to HIV by HCWs. This study was conducted to determine the prevalence of self-reported occupational exposure to HIV among HCWs and explore factors that influence the practice of managing occupational exposure to HIV by HCWs in Tanzania. Self-administered questionnaire was designed to gather information of healthcare workers' occupational exposures in the past 12 months and circumstances in which these injuries occurred. Practice of managing occupational exposure was assessed by the following questions: Nearly half of the HCWs had experienced at least one occupational injury in the past 12 months. Though most of the occupational exposures to HIV were experienced by female nurses, non-medical hospital staff received PEP more frequently than nurses and doctors. Doctors and nurses frequently encountered occupational injuries in surgery room and labor room respectively. HCWs with knowledge on the possibility of HIV transmission and those who knew whom to contact in event of occupational exposure to HIV were less likely to have poor practice of managing occupational exposure. Needle stick injuries and splashes are common among HCWs at Tumbi and Dodoma hospitals. Knowledge of the risk of HIV transmission due to occupational exposure and knowing whom to contact in event of exposure predicted practice of managing the exposure. Thus provision of health education on occupational exposure may strengthen healthcare workers' practices to manage occupational exposure
Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (riyadh cohort 2): a decade of an epidemic
<p>Abstract</p> <p>Background</p> <p>Follow-up epidemiologic studies are needed to assess trends and patterns of disease spread. No follow-up epidemiologic study has been done in the Kingdom of Saudi Arabia to assess the current prevalence of major chronic, noncommunicable diseases, specifically in the urban region, where modifiable risk factors remain rampant. This study aims to fill this gap.</p> <p>Methods</p> <p>A total of 9,149 adult Saudis ages seven to eighty years (5,357 males (58.6%) and 3,792 females (41.4%)) were randomly selected from the Riyadh Cohort Study for inclusion. Diagnosis of type 2 diabetes mellitus (DMT2) and obesity were based on the World Health Organization definitions. Diagnoses of hypertension and coronary artery disease (CAD) were based on the Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and American Heart Association criteria, respectively.</p> <p>Results</p> <p>The overall crude prevalence of DMT2 was 23.1% (95% confidence interval (95% CI) 20.47 to 22.15). The age-adjusted prevalence of DMT2 was 31.6%. DMT2 prevalence was significantly higher in males, with an overall age-adjusted prevalence of 34.7% (95% CI 32.6 to 35.4), than in females, who had an overall age-adjusted prevalence of 28.6% (95% CI 26.7 to 29.3) (<it>P </it>< 0.001). The overall crude prevalence of obesity was 31.1% (95% CI 30.1 to 32.0). The age-adjusted prevalence of obesity was 40.0%. The prevalence of obesity was higher in females, with an overall prevalence of 36.5% (95% CI 35.1 to 37.83), than in males (25.1% (95% CI 23.7 to 26.3)) (<it>P </it>< 0.001). The age-adjusted prevalence of hypertension and CAD were 32.6% (95% CI 31.7 to 33.6) and 6.9% (95% CI 6.4 to 7.4), respectively.</p> <p>Conclusion</p> <p>Comparisons of our findings with earlier data show that the prevalence of DMT2, hypertension and CAD in Riyadh, Saudi Arabia, has alarmingly worsened. Aggressive promotion of public awareness, continued screening and early intervention are pivotal to boosting a positive response.</p
- …